quinupristin-dalfopristin and Lyme-Disease

quinupristin-dalfopristin has been researched along with Lyme-Disease* in 1 studies

Other Studies

1 other study(ies) available for quinupristin-dalfopristin and Lyme-Disease

Article	Year
Sensitivity of Borrelia and Leptospira to Quinupristin-dalfopristin (Synercid) in vitro. The new microbiologica, 2001, Volume: 24, Issue:2 In vitro activity of Quinupristin-dalfopristin (Synercid) against seventeen isolates of Borrelia burgdorferi and two representatives of Leptospira spp. was investigated. MICs ranged from 0.03 to 0.125 for B. burgdorferi and 0.125-0.25 microg/ml for Leptospires. Time killing studies carried out with 2 MIC demonstrated U 3 log(10)-unit killing after 72 h, showing a significant activity against spirochetes, though at a lower level than other antibiotics in use in the therapy of Lyme disease and leptospirosis. Topics: Anti-Bacterial Agents; Borrelia burgdorferi Group; Leptospira; Lyme Disease; Microbial Sensitivity Tests; Time Factors; Virginiamycin	2001

Article

Year

Sensitivity of Borrelia and Leptospira to Quinupristin-dalfopristin (Synercid) in vitro.

The new microbiologica, 2001, Volume: 24, Issue:2

In vitro activity of Quinupristin-dalfopristin (Synercid) against seventeen isolates of Borrelia burgdorferi and two representatives of Leptospira spp. was investigated. MICs ranged from 0.03 to 0.125 for B. burgdorferi and 0.125-0.25 microg/ml for Leptospires. Time killing studies carried out with 2 MIC demonstrated U 3 log(10)-unit killing after 72 h, showing a significant activity against spirochetes, though at a lower level than other antibiotics in use in the therapy of Lyme disease and leptospirosis.

Topics: Anti-Bacterial Agents; Borrelia burgdorferi Group; Leptospira; Lyme Disease; Microbial Sensitivity Tests; Time Factors; Virginiamycin

2001